Skip to content
Home
Visit our other Journals
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
Visit
Specialties
Hematology
Oncology
Musculoskeletal Disorder
Rare Disease
Metabolic Disorder
Cardiovascular Disease
Ophthalmology
Neurology
Infectious Disease
View all Specialties
Technologies
Cell Therapy
MSC
iPSC
Gene Therapy
Genome Editing
Extracellular Vesicles
CAR-T Therapy
TCR Therapy
Tissue-Engineering & Biomaterials
View all Technologies
Topics
Treatment
Immuno-Oncology
Trial Updates
Perspectives
Manufacturing
COVID-19
View all Topics
Conferences
ASH 2022
TCT 2022
Meeting on the Med 2022
ICLE 2022
Advanced Therapies Week 2022
TERMIS 2021
ESGCT 2021
Meeting on the Mesa 2021
Advanced Therapies 2021
View all Conferences
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
Meeting on the Med 2021 and Trial Updates
View overview page
2:58
ATA188 in EBV+ progressive multiple sclerosis
Pascal Touchon
• 7 Apr 2021
1:09
SPEARHEAD-1: ADP-A2M4 in synovial sarcoma and MRCLS
Jo Brewer
• 7 Apr 2021
1:22
SURPASS: evaluating the next-generation of SPEAR T-cell therapy
Jo Brewer
• 7 Apr 2021
3:21
hESC-derived RPE for dry AMD
Jane Lebkowski
• 8 Apr 2021
2:59
Tabelecleucel in EBV-associated PTLD
Pascal Touchon
• 7 Apr 2021
2:21
A non-gene edited approach to allogeneic CAR-T development
Filippo Petti
• 6 Apr 2021
